myGVHDteam

What is the long-term prognosis given an allo transplant, GVHD with multi-organ involvement, a viral pneumonia admission, and now residual disease showing on biopsy while on active treatment?

This is a… read more

What is the long-term prognosis given an allo transplant, GVHD with multi-organ involvement, a viral pneumonia admission, and now residual disease showing on biopsy while on active treatment?

This is a genuinely complex situation, and it's completely understandable to want clarity on what lies ahead. The honest answer is that prognosis in this scenario is difficult to generalize — it really depends on how well the current treatment cycle brings those blast levels down and how the GVHD behaves going forward.

Here are some factors that are known to influence long-term outlook with chronic GVHD: - Severity and spread of GVHD — Multi-organ involvement (oral, skin, GIT) like yours is considered more significant and can affect survival odds
- Response to treatment — The fact that steroids and Jakavi improved your GVHD is an encouraging sign
- Infections — A viral pneumonia admission is a serious complication, as chronic GVHD weakens the immune system's ability to fight infections
- Residual disease — Blasts showing on biopsy adds another layer of complexity to the overall picture

The good news is that treatments are advancing, and people with GVHD are living longer than ever before. Early and active treatment — which you are clearly receiving — does improve outcomes.

That said, this situation really warrants a very direct, honest conversation with your transplant team. They have access to your full clinical picture and can give you a much more personalized prognosis than any general information can offer. Don't hesitate to ask them specifically about goals of the current treatment cycle and what the next steps look like depending on how you respond.

myGVHDteam

Great question! After a stem cell transplant, the donor cells don't simply take over everything — it's more of a coexistence, at least at first.

Before the transplant, high-dose chemotherapy (sometimes… read more

Great question! After a stem cell transplant, the donor cells don't simply take over everything — it's more of a coexistence, at least at first.

Before the transplant, high-dose chemotherapy (sometimes combined with radiation) is used to destroy the existing bone marrow. This clears the way for the donor stem cells to move in and set up shop. Once transplanted, the donor stem cells begin rebuilding the blood and immune system. Over time, they produce:

- Red blood cells that carry oxygen
- White blood cells that fight infections
- Platelets that help with clotting

So the donor cells gradually become the primary source of new blood cells. However, the rest of your body — organs, tissues, skin — remains your own. This is actually why GVHD can occur: the donor immune cells can sometimes see your body's own tissues as "foreign" and attack them.

myGVHDteam

Graft-versus-host disease (GVHD) is a complication that can occur after an allogeneic stem cell transplant (also called a bone marrow transplant), where donor cells are used. In this situation, the… read more

Graft-versus-host disease (GVHD) is a complication that can occur after an allogeneic stem cell transplant (also called a bone marrow transplant), where donor cells are used. In this situation, the donated immune cells — the "graft" — mistakenly identify the recipient's healthy cells as foreign invaders and begin to attack them, causing damage to tissues and organs. There are two main types of GVHD:

- Acute GVHD – Comes on suddenly, typically within the first 100 days after a transplant, though it can appear up to six months later
- Chronic GVHD – Develops more slowly and can last a long time, usually appearing 100 days or more after a transplant
- Overlap syndrome – When both acute and chronic GVHD occur at the same time

Symptoms can range from mild to life-threatening, depending on which organs are affected and how severe the condition is. Early diagnosis and treatment are really important for the best possible outcome.

myGVHDteam

That's a broad question — could you share a bit more about what you're looking for? For example, are you asking about:

- Treatment options for managing GVHD symptoms
- What to do if your current… read more

That's a broad question — could you share a bit more about what you're looking for? For example, are you asking about:

- Treatment options for managing GVHD symptoms
- What to do if your current treatment isn't working
- Clinical trial options
- Lifestyle or supportive care options

The more detail shared, the more helpful and specific the answer can be! 😊

myGVHDteam

A dry cough with no mucus can be a lung-related symptom of GVHD, sometimes linked to a condition called bronchiolitis obliterans syndrome (BOS), which affects the airways. The good news is that yes… read more

A dry cough with no mucus can be a lung-related symptom of GVHD, sometimes linked to a condition called bronchiolitis obliterans syndrome (BOS), which affects the airways. The good news is that yes, it can be treated, though there's no single standard approach — treatment is tailored to each person.

Steroids like the ones being taken are typically the first line of treatment. However, if symptoms aren't improving, there are additional options a doctor might consider, including:

- Inhaled corticosteroids to target the lungs more directly
- Medications like azithromycin or montelukast combined with inhaled steroids to help prevent worsening
- Systemic treatments such as ruxolitinib (Jakafi), ibrutinib (Imbruvica), or belumosudil (Rezurock)
- Extracorporeal photopheresis (ECP), a non-surgical procedure that helps reduce inflammation It's really important to let the care team know about this dry cough if they aren't already aware, especially since lung involvement in GVHD can progress. Getting on top of it early can help prevent more serious complications down the line.

myGVHDteam

First off, 10 months in — that's no small thing. Navigating chronic GVHD at 20 takes real strength, and it makes complete sense to want to connect with others on the same medication.

Since axatilimab… read more

First off, 10 months in — that's no small thing. Navigating chronic GVHD at 20 takes real strength, and it makes complete sense to want to connect with others on the same medication.

Since axatilimab is relatively new, shared patient experiences are still building up. Based on what's been reported so far, the known side effects include:

- Infections
- Muscle and joint pain
- Diarrhea
- Headache
- Fever
- Nausea Managing these side effects really comes down to open communication with your care team. If any of these feel unmanageable or are getting worse, let them know right away — they can adjust your treatment plan.

It's also worth noting that axatilimab continues until side effects become too severe or GVHD symptoms return, so tracking how you feel between infusions can be really helpful data to share with your doctor.

Other myGVHDteam members taking Niktimvo may have shared their own experiences in the community discussions — that could be a great place to find people in a similar situation to yours.